Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Cybin

Recent news which mentions Cybin

Cybin: Positive Data Announced From Innovative Drug Trial
Tags Benzinga General Cybin
From Benzinga
Cybin: Psychedelic Based BioPharma Company To Announce Much Anticipated Updates For Its Ongoing Clinical Trials
Tags Benzinga Market News Cybin
From Benzinga
Cybin Approved For First In-Human Dosing Of DMT Molecule CYB004, Milestone For Anxiety Disorder Treatment
Tickers CYBN DMT
Tags Doug Drysdale first/in/human dosing DMT
From Benzinga
Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family
Tickers CYBN MSSTF
Tags CYBN MSSTF News
From Benzinga
BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression
Tickers CYBN DEA MDD
Tags News Emerging Markets Clinilabs
From Benzinga
This Psychedelics Company Is Setting Up An Equity Program For Up To $35M In Shares
Tickers CYBN SEC
Tags Cybin Market News SEC
From Benzinga
How Does Ketamine Affect The Brain Over Time?
Tags Benzinga Ketamine contributors
From Benzinga
Cybin Presents "Why Cybin Is Investing So Heavily On Developing Novel Psychedelic Molecules" At The Psychedelic Capital Conference
Tickers CYBN
Tags Benzinga Psychedelic Capital Conference Psychedelics CYBN
From Benzinga
Cybin's Major Depressive Disorder Treatment Trials Continue With Clinilabs Drug Development Corp
Tickers CYBN
Tags CYBN General News
From Benzinga
Cybin's CYB0004 Shows Positive Preclinical Results Over Traditional Psychedelics
Tickers CYBN
Tags Benzinga Penny Stocks Cannabis
From Benzinga
WIPO Publishes Cybin's Patent Application For Inhaled Psychedelics Therapies
Tickers CYBN
Tags CYBN Psychedelics News
From Benzinga
A Builder From The Ground Up, Doug Drysdale, CEO of Cybin: Meet Our Speakers
Tickers AGN CYBN PTX
Tags Doug Drysdale AGN Startups
From Benzinga
Cybin Begins Study Using Kernel Flow Headsets To Measure Ketamine's Effects On The Brain
Tickers CYBN
Tags Market News Cybin Cannabis
From Benzinga
Cybin Completes In Vivo Preclinical Studies For Major Depressive Disorder
Tickers CYBN
Tags Markets Cannabis Market News
From Benzinga
Five Companies Developing Second Generation Psychedelics For Mental Health
Tickers CYBN ENVB FTRP MNMD
Tags Enveric Biosciences April19 Market News
From Benzinga
Cybin Reports Q2 Financial Results And Latest News, Including FDA & DEA Research Approvals
Tickers CYBN
Tags Benzinga Penny Stocks Doug Drysdale
From Benzinga
Cybin Announces Positive Data Showing Effectiveness of Psilocybin To Treat Depression
Tickers CYBN
Tags General CYBN News
From Benzinga
Cybin: FDA Authorizes Feasibility Study To Measure Ketamine's Effect On Cerebral Cortex
Tickers CYBN
Tags News Interview General
From Benzinga
Cybin Inc. (NEO: CYBN) (NYSE: CYBN) Files Two International Patent Applications In Support Of The Company's Research Phase Programs
Tickers CYBN
Tags Benzinga Global Penny Stocks
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.